A5006730360- Opioid Use Disorder Treatment
- Musculoskeletal pain and rehabilitation
- Pain Management and Opioid Use
- Spine and Intervertebral Disc Pathology
- Pain Management and Treatment
- Prenatal Substance Exposure Effects
- Cannabis and Cannabinoid Research
- Mental Health and Psychiatry
- Hemodynamic Monitoring and Therapy
- Pain Management and Placebo Effect
- Pharmaceutical Practices and Patient Outcomes
- Psychosomatic Disorders and Their Treatments
- Cardiac Arrest and Resuscitation
- Ethics in medical practice
- Healthcare Decision-Making and Restraints
- Traumatic Brain Injury and Neurovascular Disturbances
- Trigeminal Neuralgia and Treatments
- Scoliosis diagnosis and treatment
- Anesthesia and Pain Management
- Empathy and Medical Education
- Body Image and Dysmorphia Studies
- Transcranial Magnetic Stimulation Studies
- Treatment of Major Depression
Fox Corporation (United States)
2024
Tufts University
2017-2019
Center for Pain and the Brain
2016-2019
Clinical Solutions
2015
Objective: To evaluate clinical outcomes and health care utilization at 12 months post spinal cord stimulator (SCS) implantation compared with baseline a matched sample of patients receiving conventional medical management (CMM) for the treatment low back lower extremity pain. Patients: A retrospective study least 24 active an interdisciplinary community pain center between December 1, 2014 31, 2017. Thirty-two high-frequency (10 kHz) SCS 64 CMM were identified through propensity matching...
Health care providers are likely to see an increase in the concomitant use of cannabis and opioids, particularly with increased liberalization ongoing research into possible role medical marijuana for chronic pain. Recent literature reports a prevalence concurrent ranging from 8.9% 31.8%. The primary aim this study was determine relationship between aberrant drug behaviors noncancer pain patients receiving opioid therapy.Retrospective chart review.Community-based, interdisciplinary...
To determine the relationship between opioid dose change, pain severity, and function in patients with chronic pain.Retrospective cohort study.Community interdisciplinary management practice.A total of 778 prescribed opioids for three or more consecutive months April 1, 2013, March 2015.Changes dose, severity rating, modified Roland Morris Disability Questionnaire score, risk data were extracted from medical records analyzed associations.Two hundred forty-three subjects (31.2%) had an...
To examine the validity of World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for assessment function in a community-based sample patients with chronic pain conditions undergoing evaluation opioid therapy.One hundred nine 124 were evaluated therapy program between December 1, 2014 and April 10, 2015, inclusive, at one interdisciplinary management practice. Measures included: demographic data; WHODAS 2.0; modified version Roland Morris Questionnaire (RMDQ-m); Patient...
Overdoses (ODs) of prescription opioids (RxOs) have become a major public health issue in the United States.Objective: To determine root causes accidental opioid overdoses (RxO-OD).Design/setting/participants/intervention: The authors conducted cause analysis using Antecedent Target-Measurement method, interviewing three types key informants: survivors RxO-ODs, family members, and clinical experts.Results: Ten survivors, five experts were interviewed. Proximal RxO-ODs described by members...
To determine the average amount of time required to detect opioid aberrancy based upon varying frequencies urine drug testing (UDT) in a community-based, tertiary care pain management center.This study was retrospective analysis 513 consecutive patients enrolled medication program, receiving chronic therapy between January 1, 2018 and December 31, 2018.Data were extracted from medical records including age at start period, sex, ethnicity, marital status, smoking status. UDT performed each...
Background Orofacial pain is a specialty of dentistry that often encounters complex symptoms beyond the scope dental practice, indicating role for interprofessional teams in treating chronic orofacial pain.
Background Oxygen is critical to the prevention of hypoxemia-induced morbidity and mortality; yet, access remains inadequate in most low- middle-income countries despite billions dollars spent over decades increase supply. We present a new method for supplemental oxygen delivery whereby OXFO System (OXFO Corporation, Boston, MA, USA) converts pressurized ambient pressure patient inhalation on demand at fixed concentration across fluctuations respiratory rate or tidal volume. This study’s...